Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation
Publication
, Conference
Ezekian, B; Kwun, J; Manook, M; Freischlag, K; Curfman, V; Branum, E; Park, J; Yi, J; Jordan, S; Knechtle, S
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
April 1, 2017
Duke Scholars
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
April 1, 2017
Volume
17
Start / End Page
211 / 211
Location
Chicago, IL
Publisher
WILEY
Conference Name
American Transplant Congress
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ezekian, B., Kwun, J., Manook, M., Freischlag, K., Curfman, V., Branum, E., … Knechtle, S. (2017). Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 17, pp. 211–211). Chicago, IL: WILEY.
Ezekian, B., J. Kwun, M. Manook, K. Freischlag, V. Curfman, E. Branum, J. Park, J. Yi, S. Jordan, and S. Knechtle. “Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation.” In AMERICAN JOURNAL OF TRANSPLANTATION, 17:211–211. WILEY, 2017.
Ezekian B, Kwun J, Manook M, Freischlag K, Curfman V, Branum E, et al. Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation. In: AMERICAN JOURNAL OF TRANSPLANTATION. WILEY; 2017. p. 211–211.
Ezekian, B., et al. “Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 17, WILEY, 2017, pp. 211–211.
Ezekian B, Kwun J, Manook M, Freischlag K, Curfman V, Branum E, Park J, Yi J, Jordan S, Knechtle S. Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY; 2017. p. 211–211.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
April 1, 2017
Volume
17
Start / End Page
211 / 211
Location
Chicago, IL
Publisher
WILEY
Conference Name
American Transplant Congress
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences